FDA Releases Statement on Changing Dosing of COVID Immunizations

In a statement on the suggestion that the dosing of COVID immunizations be changed, the Food and Drug Administration (FDA) said, “We have been following the discussions and news reports about reducing the number of doses, extending the length of time between doses, changing the dose (half-dose), or mixing and matching vaccines in order to immunize more people against COVID-19. These are all reasonable questions to consider and evaluate in clinical trials. However, at this time, suggesting changes to the FDA-authorized dosing or schedules of these vaccines is premature and not rooted solidly in the available evidence.”